Lam Research Stock Tumbles on Report of Chinese Chip Equipment Breakthrough

Shares of Lam Research (LRCX) plummeted 7.9% in mid-day trading Monday following a report that a state-backed Chinese company has started mass-producing homegrown deep ultraviolet (DUV) lithography machines. The development marks a potential turning point in China's push for semiconductor self-sufficiency and poses a direct competitive threat to Western equipment suppliers.

China's Technological Advance

According to a report from The Information, a Shanghai-based firm has successfully developed and is now manufacturing immersion DUV lithography systems. These crucial tools, previously dominated by a handful of international companies, are reportedly set to be delivered this year to major domestic chipmakers, including Semiconductor Manufacturing International Corp (SMIC) and Hua Hong Semiconductor.

The news signals a significant step in Beijing's efforts to build an independent semiconductor supply chain, reducing its reliance on foreign technology. For companies like Lam Research, this shift could disrupt a critical and lucrative market.

Market Reaction and Sector Impact

The report triggered a broad selloff across the semiconductor equipment sector, as investors weighed the long-term implications of increased competition from China.

Ad

• Lam Research was hit particularly hard due to its high exposure to the region; China accounts for approximately 34-35% of the company's total revenue.
• Peers also fell in a sympathy move, with notable declines in shares of ASML, Applied Materials, and KLA Corp.
• The sector's sharp drop contrasted with the broader market, where the Nasdaq Composite was down just 0.4% and the S&P 500 slipped 0.1%, underscoring the specific nature of the concerns.

Pre-existing Headwinds

Today's news crystallized pre-existing investor concerns that had left the stock vulnerable. Lam Research has recently contended with stretched valuations following a strong rally, uncertainty around ongoing U.S. export controls targeting China, and significant insider selling, including a director's sale of over $19 million in shares.

Investors are now looking ahead to Lam Research's quarterly earnings call, scheduled for July 29, for management's commentary on the competitive landscape. The market is also bracing for a Federal Reserve policy decision later this week, which adds a layer of macroeconomic uncertainty.